EMFAT
RVMD icon

Emerald Mutual Fund Advisers Trust’s Revolution Medicines RVMD Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-45,918
Closed -$1.01M – 328
2020
Q1 		$1.01M Buy
+45,918
New +$1.27M 0.06% 160

Other funds holding RVMD

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's RVMD Position: Q2 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Revolution Medicines (RVMD) in Q2 2020, closing a stake of 45,918 shares — an estimated $1.01M sold.

Emerald Mutual Fund Advisers Trust first reported a position in RVMD in Q1 2020 and held it in 1 quarter. The position peaked at $1.01M in Q1 2020. 77 funds tracked by Wall St. Rank hold RVMD as of Q2 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Revolution Medicines position as of Q2 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 45,918 Revolution Medicines shares in Q2 2020, an estimated $1.01M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Revolution Medicines in Q1 2020 and held it in 1 quarter.
  • Emerald Mutual Fund Advisers Trust's Revolution Medicines position peaked at $1.01M in Q1 2020.
  • 77 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2020, filed 28 Jul 2020.